These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 21764271

  • 1. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
    Li F, Sun J, Zhu H, Wen X, Lin C, Shi D.
    Colloids Surf B Biointerfaces; 2011 Nov 01; 88(1):58-62. PubMed ID: 21764271
    [Abstract] [Full Text] [Related]

  • 2. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.
    Nanomedicine; 2007 Dec 01; 3(4):246-57. PubMed ID: 18068091
    [Abstract] [Full Text] [Related]

  • 3. Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies.
    Zhu L, Ma J, Jia N, Zhao Y, Shen H.
    Colloids Surf B Biointerfaces; 2009 Jan 01; 68(1):1-6. PubMed ID: 19013060
    [Abstract] [Full Text] [Related]

  • 4. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ, Tong YW, Yang YY.
    Biomaterials; 2005 Aug 01; 26(24):5064-74. PubMed ID: 15769542
    [Abstract] [Full Text] [Related]

  • 5. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.
    Tahara K, Kato Y, Yamamoto H, Kreuter J, Kawashima Y.
    J Microencapsul; 2011 Aug 01; 28(1):29-36. PubMed ID: 21171814
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I, Rabiee M, Hosseini MS, Mozafari M.
    Appl Biochem Biotechnol; 2012 Nov 01; 168(6):1434-47. PubMed ID: 22976852
    [Abstract] [Full Text] [Related]

  • 7. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
    Lin R, Shi Ng L, Wang CH.
    Biomaterials; 2005 Jul 01; 26(21):4476-85. PubMed ID: 15701377
    [Abstract] [Full Text] [Related]

  • 8. pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery.
    Li Z, Qiu L, Chen Q, Hao T, Qiao M, Zhao H, Zhang J, Hu H, Zhao X, Chen D, Mei L.
    Acta Biomater; 2015 Jan 01; 11():137-50. PubMed ID: 25242647
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L, Hou L, Guo D, Xiao X, Mao P, Yang X.
    Int J Pharm; 2012 Oct 15; 436(1-2):815-24. PubMed ID: 22846410
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
    Li JL, Zheng CL, Liu JP, Zhu JB.
    Yao Xue Xue Bao; 2013 May 15; 48(5):759-66. PubMed ID: 23888702
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer.
    Kim I, Byeon HJ, Kim TH, Lee ES, Oh KT, Shin BS, Lee KC, Youn YS.
    Biomaterials; 2012 Aug 15; 33(22):5574-83. PubMed ID: 22579235
    [Abstract] [Full Text] [Related]

  • 15. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B, Devi KS, Banerjee R, Maiti TK, Pramanik P, Dhara D.
    ACS Appl Mater Interfaces; 2013 May 15; 5(9):3884-93. PubMed ID: 23551195
    [Abstract] [Full Text] [Related]

  • 16. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D, Foged C, Yang M, Frøkjaer S, Nielsen HM.
    Int J Pharm; 2010 May 05; 390(1):70-5. PubMed ID: 19836438
    [Abstract] [Full Text] [Related]

  • 17. Ultrasound-triggered drug release and enhanced anticancer effect of doxorubicin-loaded poly(D,L-lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanodroplets.
    Du L, Jin Y, Zhou W, Zhao J.
    Ultrasound Med Biol; 2011 Aug 05; 37(8):1252-8. PubMed ID: 21683513
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
    Jain AK, Swarnakar NK, Das M, Godugu C, Singh RP, Rao PR, Jain S.
    Mol Pharm; 2011 Aug 01; 8(4):1140-51. PubMed ID: 21557558
    [Abstract] [Full Text] [Related]

  • 20. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
    Misra R, Sahoo SK.
    Eur J Pharm Sci; 2010 Jan 31; 39(1-3):152-63. PubMed ID: 19961929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.